|
|
|
KEY ISSUES
QUALITY SYSTEM
Periodic inspections/surveillance assessments by regulatory compliance bodies, complaint handling, MDR/Vigilance reporting, recall/corrections, establishment registration, and device listing updates
DESIGN CONTROL
Product changes initiating new or revised design effort
CLINICAL TRIAL CONSIDERATIONS
Mandated post-market surveillance studies
PREMARKET SUBMISSION CONSIDERATIONS
Product changes prompting new or revised submission
|
|
|
|
|
|
|
You've made it to the marketplace, but your ability to maintain product viability is constantly challenged. Whether introducing changes to the device, monitoring actual use success rates, or dealing with occasional inspections, MDCI can help you stay in business.
We provide consulting on regulatory compliance issues:
- Preparation for FDA inspections and registrar or Notified Body assessments
- Enforcement action responses and/or corrective action plans
- FDA-mandated Annual Certification Audits
- Recall strategies
- Due diligence audits
- Facility registration and device listing
- U. S. Agent Service
- European Authorized Representative
And we can handle post-market surveillance:
- Complaint handling, MDR and Vigilance reporting, failure investigation, and problem reporting
- Device tracking
We also design and manage post-market studies, provide temporary on-site quality/compliance staffing and support, and perform product change assessments for regulatory submission impact:
- Premarket approval (PMA) Supplements
- Premarket notifications [510(k)s]
Speak with a Consultant
Reach our Massachusetts office at 1-508-643-0434, Monday through Friday, 9:00 a.m. to 5:00 p.m. Eastern. Or click here and a consultant will contact you directly.
|
|